Gene Editing Using CRISPR: 2016 Top 10 Medical Innovation
Gene Editing Using CRISPR: 2016 Top 10 Medical Innovation
Learn about one of Cleveland Clinic’s Top 10 Innovations for 2016, gene editing using CRISPR. CRISPR is a therapy in which the human genome is altered in an effort to eliminate genetic-based disease.
➨ Visit Cleveland Clinic: http://bit.ly/XlxDfr
➨ Visit Health Hub from Cleveland Clinic: http://bit.ly/VBQ3nW
➨ Subscribe to our YouTube Channel: http://bit.ly/W0bJ0y
➨ Like Cleveland Clinic on Facebook: http://on.fb.me/WMFkul
➨ Follow Cleveland Clinic on Twitter: http://bit.ly/Uua1Gs
➨ Follow Cleveland Clinic on Google+: http://bit.ly/136vcTe
➨ Follow Cleveland Clinic on Instagram: http://bit.ly/12gMABx
➨ Connect with Cleveland Clinic on LinkedIn: http://linkd.in/120XfNs
➨ Follow Cleveland Clinic on Pinterest: http://bit.ly/11QqS3A
- CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
- CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
- The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
- The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
- ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
- The Dark Side of CRISPR – Scientific American
- ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
- Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
- DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
- CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
- Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
- New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
- After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
Leave a Reply
You must be logged in to post a comment.